Open Nav

NeoTX Holdings Ltd.

Add investors

  • Date:Wednesday, October 17
  • Time:11:15 AM - 11:30 AM
  • Room:Elizabethan B
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.
  • Company
  • Company HQ City:Rehovot, Israel
  • Company HQ Country:Israel
  • CEO/Top Company Official:Asher Nathan
  • Year Founded:2014
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development :ANYARA
  • Development Phase of Primary Product:Pre-Clinical